Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders.
Nencini F, Vultaggio A, Pratesi S, Cammelli D, Milla M, Fiori G, Bagnoli S, Prignano F, Romagnani S, Maggi E, Matucci A. Nencini F, et al. Among authors: bagnoli s. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2065-2072.e2. doi: 10.1016/j.jaip.2018.04.007. Epub 2018 Apr 13. J Allergy Clin Immunol Pract. 2018. PMID: 29660428
The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey.
Dragoni G, Ding N, Gecse KB, Mansfield JC, Kopylov U, Beaugerie L, Bossuyt P, Sebastian S, Milla M, Bagnoli S, Yassin NA, Bettenworth D, Burisch J, Hedin C, Gisbert JP, Ferrante M; Clinical Research Committee (ClinCom) of ECCO and Young ECCO Committee (Y-ECCO). Dragoni G, et al. Among authors: bagnoli s. Eur J Gastroenterol Hepatol. 2020 Aug;32(8):1062-1066. doi: 10.1097/MEG.0000000000001729. Eur J Gastroenterol Hepatol. 2020. PMID: 32282539
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry.
Tapete G, Bertani L, Pieraccini A, Lynch EN, Giannotta M, Morganti R, Biviano I, Naldini S, Mumolo MG, De Nigris F, Calella F, Bagnoli S, Minciotti M, Maltinti S, Rentini S, Ceccarelli L, Lionetti P, Milla M, Costa F. Tapete G, et al. Among authors: bagnoli s. Inflamm Bowel Dis. 2022 Jan 5;28(1):62-69. doi: 10.1093/ibd/izab027. Inflamm Bowel Dis. 2022. PMID: 33570142
243 results